疫苗细胞培养基市场按培养基类型、应用和地区划分

疫苗细胞培养基市场预计到 2026 年将价值 22.176 亿美元，预计到 2033 年将达到 37.274 亿美元，2026 年至 2033 年的年复合成长率（CAGR）为 7.7%。

细胞培养基包含适当的能源来源以及支持细胞生长和调节细胞週期的化合物。典型的细胞培养基包含维生素、无机盐、胺基酸补充剂、葡萄糖和血清，血清作为生长因子、荷尔蒙和黏附因子的来源。此外，培养基也有助于维持pH值和渗透压。

市场动态

感染疾病的上升趋势是推动全球疫苗细胞培养基市场成长的主要因素。根据美国疾病管制与预防中心（CDC）统计，2017年8月美国报告了约104例经检查室确诊的流感相关儿童死亡病例，其中66例与甲型流感病毒相关，38例与乙型流感病毒相关。此外，政府为意识提升而采取的措施预计也将推动市场成长。例如，根据美国疾病管制与预防中心（CDC）统计，2015年流感疫苗接种预防了约190万例流感病例、96.6万例流感相关就诊和约6.7万例流感相关住院，使美国的疾病负担降低了6.5%。

然而，污染风险较高可能会阻碍市场成长：根据 ResearchGate 2014 年的一篇报导，已知牛(FBS) 含有内毒素、霉浆菌、病毒污染物和朊病毒等因素，这些因素会导致牛脑病变(BSE)。

本次调查的主要特点

• 本报告详细分析了全球疫苗细胞培养基市场，以 2017 年为基准年，给出了预测期（2018-2026 年）的市场规模和复合年增长率。
• 它还重点介绍了各个细分市场的潜在商机，并解释了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、影响分析、波特五力分析、PEST 分析、监管环境、关键发展、原材料分析和供应链分析的重要见解。
• 本报告根据以下参数对全球疫苗细胞培养基市场的主要企业进行了分析：公司概况、财务绩效、产品系列、市场地位、分销策略、主要发展、策略和未来计划。
• 本报告的研究结果将帮助负责人和经营团队就未来的产品推出、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球疫苗细胞培养基市场报告的目标受众是该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过全球疫苗细胞培养基市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、监理及趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • 市场机会
• 影响分析
• 波特分析
• PEST分析
• 法规环境
• 重大进展
• 原料分析
• 供应链分析

4. 2026-2033年全球疫苗细胞培养基市场（依培养基类型划分）

• 牛衍生
• 牛（FBS）
• 新生牛血清（NBCS）
• 牛血清（ABS）
• 牛血清白蛋白（BSA）
• 牛血清（BCS）
• 源自猪
• 不含动物性成分/无血清细胞培养

5. 2026-2033年全球疫苗细胞培养基市场（依应用领域划分）

• 人类疫苗
• 兽用疫苗

6. 2026-2033年全球疫苗细胞培养基市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • GCC
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 中非
  • 北非

第七章 竞争情势

• 热图分析
• 公司简介
  • HiMedia Laboratories
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • General Electric Company
  • Sartorius AG
  • Proliant, Inc.
  • Bovogen Biologicals Pty. Ltd.
  • Rocky Mountain Biologicals
  • Valley Biomedical
  • Moregate BioTech
  • Atlanta Biologicals
  • Creative-Biolabs
  • Life Technologies（India）Pvt Ltd.
  • Axil Scientific Pte Ltd.
  • Indian Immunologicals Limited
  • Serum Institute of India Pvt. Ltd.
  • Valneva SE

第八章各节

• 参考
• 调查方法

Cell Culture Media For Vaccine Market is estimated to be valued at USD 2,217.6 Mn in 2026 and is expected to reach USD 3,727.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).

Key features of the study

• This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter's analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
• It profiles key players in the global cell culture media for vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market

Market Segmentation

• By Media Type
  • Bovine Derived
  • Fetal bovine serum (FBS)
  • Newborn Calf Serum (NBCS)
  • Adult Bovine Serum (ABS)
  • Bovine Serum Albumin (BSA)
  • Bovine Calf Serum (BCS)
  • Porcine Derived
  • Animal free/Serum Free Cell Culture
• By Application
  • Human Vaccines
  • Animal Vaccines
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • HiMedia Laboratories
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • General Electric Company
  • Sartorius AG
  • Proliant, Inc.
  • Bovogen Biologicals Pty. Ltd.
  • Rocky Mountain Biologicals
  • Valley Biomedical
  • Moregate BioTech
  • Atlanta Biologicals
  • Creative-Biolabs
  • Life Technologies (India) Pvt Ltd.
  • Axil Scientific Pte Ltd.
  • Indian Immunologicals Limited
  • Serum Institute of India Pvt. Ltd.
  • Sisco Research Laboratories Pvt. Ltd.
  • Valneva SE

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Media Type
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Porter's analysis
• PEST analysis
• Regulatory Scenario
• Key Developments
• Raw material analysis
• Supply chain analysis

4. Global Cell Culture Media for Vaccine Market, By Media Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Bovine Derived
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Fetal bovine serum (FBS)
• Newborn Calf Serum (NBCS)
• Adult Bovine Serum (ABS)
• Bovine Serum Albumin (BSA)
• Bovine Calf Serum (BCS)
• Porcine Derived
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Animal free/Serum Free Cell Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Cell Culture Media for Vaccine Market, By Application, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Human Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Animal Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Cell Culture Media for Vaccine Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
• North America
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • HiMedia Laboratories
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Merck KGaA
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • General Electric Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Sartorius AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Proliant, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Bovogen Biologicals Pty. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Rocky Mountain Biologicals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Valley Biomedical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Moregate BioTech
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Atlanta Biologicals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Creative-Biolabs
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Life Technologies (India) Pvt Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Axil Scientific Pte Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Indian Immunologicals Limited
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Valneva SE
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

8. Section

• References
• Research Methodology
• About us and Sales Contact